depemokimab-ulaa 100 MG in 1 ML Prefilled Syringe

RxCUI
2729271
RxNorm name
depemokimab-ulaa 100 MG in 1 ML Prefilled Syringe
Display name
depemokimab-ulaa 100 MG in 1 ML Prefilled Syringe
Full name
depemokimab-ulaa 100 MG in 1 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761458Exdensurdepemokimab-ulaa351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ExdensurDEPEMOKIMABGlaxoSmithKline LLC30332b20-2ac0-42ad-a775-d3ca7f5fe29f2026-06-10Warnings, Adverse reactionsExact identifier
rxcui: 2729271

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
30332b20-2ac0-42ad-a775-d3ca7f5fe29fdepemokimab-ulaa 100 MG in 1 ML Prefilled SyringePSN3These highlights do not include all the information needed to use EXDENSUR safely and effectively. See full prescribing information for EXDENSUR. EXDENSUR (depemokimab-ulaa) injection, for subcutaneous use Initial U.S. Approval: 202520251216
30332b20-2ac0-42ad-a775-d3ca7f5fe29fdepemokimab-ulaa 100 MG per 1 ML Prefilled SyringeSY3These highlights do not include all the information needed to use EXDENSUR safely and effectively. See full prescribing information for EXDENSUR. EXDENSUR (depemokimab-ulaa) injection, for subcutaneous use Initial U.S. Approval: 202520251216
30332b20-2ac0-42ad-a775-d3ca7f5fe29f1 ML depemokimab-ulaa 100 MG/ML Prefilled SyringeSCD3These highlights do not include all the information needed to use EXDENSUR safely and effectively. See full prescribing information for EXDENSUR. EXDENSUR (depemokimab-ulaa) injection, for subcutaneous use Initial U.S. Approval: 202520251216